Abiopharma

Vicarious Surgical Inc. - Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions

Stepan Announces Agreement to Sell Lake Providence, LA Assets

Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook

BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition

OKYO Pharma Announces Chairman and Founder Acquires Shares

Bristol Myers Squibb - Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimers Disease

Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimers Disease

Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimers Disease